Biologicals

Technical report series: cytokines

Biological products, rDNA

Title: Biological products prepared by recombinant DNA technology; Adopted 1990, TRS No 814, Annex 3

Interferons, human

Title: Requirements for Human Interferons prepared from Lymphoblastoid Cells; Adopted 1988, TRS No 786, Annex 3

Interferons, human

Title: Requirements for Human interferons made by recombinant DNA techniques; Adopted 1987, TRS No 771, Annex 7

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



TSN LUNCHTIME SEMINAR

UPCOMING EVENTS


  • TCV Workshop, NIBSC, Potters Bar, UK, 8-10 March 2016
  • WHO informal consultation on labelling information on influenza vaccines intended to be used for pregnant women, Geneva, Switzerland, 4-5 April 2016
  • WHO informal consultation on WHO guidelines on regulatory preparedness for vaccine non-producing countries in response to pandemic influenza emergency, Geneva, Switzerland, 6-7 April 2016
  • WHO working group meeting on guidelines on the quality, safety and efficacy of Ebola vaccines, Geneva, Switzerland, 4-5 May 2016

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971